Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Invested Capital: 2011-2025

Historic Invested Capital for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $13.7 million.

  • Fennec Pharmaceuticals' Invested Capital fell 44.77% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 44.77%. This contributed to the annual value of $12.3 million for FY2024, which is 32.89% down from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Invested Capital of $13.7 million as of Q3 2025, which was up 27.66% from $10.7 million recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Invested Capital ranged from a high of $34.6 million in Q3 2023 and a low of $2.8 million during Q3 2022.
  • In the last 3 years, Fennec Pharmaceuticals' Invested Capital had a median value of $17.7 million in 2023 and averaged $20.1 million.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Invested Capital crashed by 88.33% in 2022, and later skyrocketed by 1,134.15% in 2023.
  • Over the past 5 years, Fennec Pharmaceuticals' Invested Capital (Quarterly) stood at $24.0 million in 2021, then crashed by 88.33% to $22.4 million in 2022, then decreased by 18.07% to $18.4 million in 2023, then slumped by 32.89% to $12.3 million in 2024, then slumped by 44.77% to $13.7 million in 2025.
  • Its Invested Capital was $13.7 million in Q3 2025, compared to $10.7 million in Q2 2025 and $12.3 million in Q1 2025.